These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20937920)

  • 1. The vital amines: too much of a good thing?: comment on "Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality".
    Tice JA
    Arch Intern Med; 2010 Oct; 170(18):1631-3. PubMed ID: 20937920
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals.
    Clarke R; Halsey J; Lewington S; Lonn E; Armitage J; Manson JE; Bønaa KH; Spence JD; Nygård O; Jamison R; Gaziano JM; Guarino P; Bennett D; Mir F; Peto R; Collins R;
    Arch Intern Med; 2010 Oct; 170(18):1622-31. PubMed ID: 20937919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials.
    B-Vitamin Treatment Trialists' Collaboration
    Am Heart J; 2006 Feb; 151(2):282-7. PubMed ID: 16442889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials.
    Ebbing M; Bønaa KH; Arnesen E; Ueland PM; Nordrehaug JE; Rasmussen K; Njølstad I; Nilsen DW; Refsum H; Tverdal A; Vollset SE; Schirmer H; Bleie Ø; Steigen T; Midttun Ø; Fredriksen A; Pedersen ER; Nygård O
    J Intern Med; 2010 Oct; 268(4):367-82. PubMed ID: 20698927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate supplementation: too much of a good thing?
    Ulrich CM; Potter JD
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):189-93. PubMed ID: 16492904
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of folic acid on cerebrovascular and cancer risks].
    Martin-Du Pan RC; Mercan D
    Rev Med Suisse; 2012 Feb; 8(328):375-9. PubMed ID: 22397069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine, folic acid, B vitamins and cardiovascular risk.
    Blacher J; Safar ME
    J Nutr Health Aging; 2001; 5(3):196-9. PubMed ID: 11458292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocysteine-lowering trials for prevention of heart disease and stroke.
    Clarke R
    Semin Vasc Med; 2005 May; 5(2):215-22. PubMed ID: 16047274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine-lowering vitamins and cardiovascular mortality: are they really effective?
    Celik T; Iyisoy A; Yuksel UC; Isik E
    Int J Cardiol; 2008 Aug; 128(3):432-3. PubMed ID: 17689750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of homocysteine interventions on the risk of cardiocerebrovascular events: a meta-analysis of randomised controlled trials.
    Mei W; Rong Y; Jinming L; Yongjun L; Hui Z
    Int J Clin Pract; 2010 Jan; 64(2):208-15. PubMed ID: 19912385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vitamin treatments that lower homocysteine concentration: can they decrease cerebrovascular disease in primary prevention?].
    Méndez-González J; Rodríguez-Millán E; Julve J; Blanco-Vaca F
    Rev Neurol; 2010 Feb 16-28; 50(4):235-44. PubMed ID: 20198596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Homocysteine lowering with folic acid and B vitamins in vascular disease].
    Liakishev AA
    Kardiologiia; 2006; 46(5):70. PubMed ID: 16858361
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of folic acid supplementation in cardiovascular disease prevention: an updated meta-analysis of randomized controlled trials.
    Yang HT; Lee M; Hong KS; Ovbiagele B; Saver JL
    Eur J Intern Med; 2012 Dec; 23(8):745-54. PubMed ID: 22884409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
    Heinz J; Kropf S; Luley C; Dierkes J
    Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine, B-vitamins, and the risk of cardiovascular disease.
    Clarke R; Smulders Y; Fowler B; Stehouwer CD
    Semin Vasc Med; 2005 May; 5(2):75-6. PubMed ID: 16047260
    [No Abstract]   [Full Text] [Related]  

  • 17. Homocysteine, B-vitamins and CVD.
    McNulty H; Pentieva K; Hoey L; Ward M
    Proc Nutr Soc; 2008 May; 67(2):232-7. PubMed ID: 18412997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine lowering and cardiovascular disease risk: lost in translation.
    Marcus J; Sarnak MJ; Menon V
    Can J Cardiol; 2007 Jul; 23(9):707-10. PubMed ID: 17622392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial.
    Heinz J; Kropf S; Domröse U; Westphal S; Borucki K; Luley C; Neumann KH; Dierkes J
    Circulation; 2010 Mar; 121(12):1432-8. PubMed ID: 20231532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of recurrent cardiovascular events in patients with increased plasma homocysteine levels is reduced by short but not long-term therapy with folate and B vitamins.
    Siragusa S; Malato A; Cigna V; Anastasio R; Coco LL; Casuccio A; Ciaccio M
    Thromb Res; 2007; 121(1):51-3. PubMed ID: 17462714
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.